{
  "abstract": "Background: The National Health Service (NHS) Cancer Vaccine Launch Pad (CVLP) is a research study designed to develop national patient referral and tumour tissue processing pathways to support patients with cancer to access commercial cancer vaccine and other targeted immunotherapy clinical trials. Recent advances in nucleic acid technology, tumour sequencing and immuno-oncology have renewed interest in cancer vaccines and other targeted immunotherapies. The CVLP aims to accelerate translation to routine care by assessing the feasibility of integrating patient screening, consent, biological sample handling and genomic profiling across the NHS to support access to these trials. This will prepare the NHS for wider implementation should these novel therapeutics be adopted.\n\nMethods and analysis: The CVLP (ISRCTN13053675) is a multicentre prospective observational cohort feasibility study, sponsored by NHS England and coordinated by the Cancer Research UK Southampton Clinical Trials Unit (SCTU). Via an academically led protocol, adult participants will be recruited from participating NHS locations. Consent will be obtained for the use of routinely collected demographic and clinical data alongside access to surplus tumour tissue and other biological samples for molecular analysis. This will serve to guide trial eligibility and onward referral to commercial trials open in the UK. Initial feasibility of the CVLP platform will be assessed via recruitment rates, timeliness of tumour tissue and biological sample handling and the proportion of participants referred onward to commercial clinical trials on the CVLP portfolio. Analysis will be descriptive, summarising recruitment metrics, pathway timelines and follow-up outcomes.\n\nEthics and dissemination: This study received ethical approval from East of England—Essex Research Ethics Committee on 20 August 2023 (23/EE/0178). Findings will be disseminated through peer-reviewed publications, scientific meetings and stakeholder reports to inform national delivery models for NHS cancer services. Lay summaries of study progress and findings will be published on the SCTU website.\n\nTrial registration number: ISRCTN13053675.",
  "abstract_shown": true,
  "affiliations": [
    "Cancer Research UK Southampton Clinical Trials Unit, University of Southampton, Southampton, UK",
    "Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK",
    "University Hospital Southampton NHS Foundation Trust, Southampton, UK",
    "Faculty of Medicine, University of Southampton, Southampton, UK",
    "NHS England, London, UK",
    "Royal Free London NHS Foundation Trust, London, UK",
    "NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK",
    "Department of Oncology, University of Oxford, Oxford, UK",
    "Oxford University Hospitals NHS Foundation Trust, Oxford, UK",
    "BC Platforms Ltd Oy, Espoo, Finland",
    "Clinical Informatics Research Unit, University of Southampton, Southampton, UK",
    "GenQA, Laboratory Medicine, NHS Lothian, Royal Infirmary of Edinburgh, Edinburgh, UK"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 27,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Benjamin Moxley-Wyles",
      "orcid": "0000-0002-0912-9324"
    },
    {
      "affs": [
        0
      ],
      "name": "Nicole Keyworth"
    },
    {
      "affs": [
        0
      ],
      "name": "Victoria M Goss"
    },
    {
      "affs": [
        0
      ],
      "name": "Samuel Goode"
    },
    {
      "affs": [
        0
      ],
      "name": "Laura Pope"
    },
    {
      "affs": [
        0
      ],
      "name": "Tiffany Joyce"
    },
    {
      "affs": [
        0
      ],
      "name": "Jeny Mathew"
    },
    {
      "affs": [
        0
      ],
      "name": "Charlotte M Stuart"
    },
    {
      "affs": [
        0,
        2
      ],
      "name": "Sarah Chamberlain"
    },
    {
      "affs": [
        0
      ],
      "name": "Jessica Curtis"
    },
    {
      "affs": [
        0,
        2
      ],
      "name": "Dan Muller"
    },
    {
      "affs": [
        2,
        3
      ],
      "name": "Emily C Shaw"
    },
    {
      "affs": [
        4
      ],
      "name": "Max Shen"
    },
    {
      "affs": [
        4
      ],
      "name": "Nicola Chapman-Hart"
    },
    {
      "affs": [
        4
      ],
      "name": "Molly Obadiah"
    },
    {
      "affs": [
        4
      ],
      "name": "Patrick Ezeani"
    },
    {
      "affs": [
        4
      ],
      "name": "Gillian Rosenberg"
    },
    {
      "affs": [
        4
      ],
      "name": "Jane Starczynski"
    },
    {
      "affs": [
        5
      ],
      "name": "Sarrah Tayabali"
    },
    {
      "affs": [
        6
      ],
      "name": "Katrina Cathie"
    },
    {
      "affs": [
        7,
        8
      ],
      "name": "Lennard YW Lee"
    },
    {
      "affs": [
        9
      ],
      "name": "Pivi Tikka-Kleemola",
      "orcid": "0000-0003-3348-0760"
    },
    {
      "affs": [
        10
      ],
      "name": "James Batchelor"
    },
    {
      "affs": [
        11
      ],
      "name": "Zandra C Deans"
    },
    {
      "affs": [
        0,
        2
      ],
      "name": "Simon Crabb"
    },
    {
      "affs": [
        0,
        2
      ],
      "name": "Gareth Griffiths"
    },
    {
      "affs": [
        2,
        4
      ],
      "name": "Peter WM Johnson"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/4ncg7mfxe304m.bib",
  "cited_by": 0,
  "doi": "10.1136/bmjopen-2026-124300",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13756454/",
  "id": "4ncg7mfxe304m",
  "issns": [
    "2044-6055",
    "2044-6055"
  ],
  "landing_url": "https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-124300",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "1506"
    ],
    [
      "heading",
      "1717"
    ],
    [
      "heading",
      "Oncology"
    ],
    [
      "heading",
      "Protocol"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": "PMC13756454",
  "pmid": "43003468",
  "published": "2026-11-09",
  "publisher": "BMJ",
  "ris": "https://research.draconitic.com/paper/4ncg7mfxe304m.ris",
  "sources": [
    {
      "first_seen": "2026-11-10T12:23:29Z",
      "native_id": "10.1136/bmjopen-2026-124300",
      "source": "crossref",
      "url": "https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-124300"
    },
    {
      "first_seen": "2026-11-16T12:22:19Z",
      "native_id": "PMC13756454",
      "source": "pmc",
      "url": "https://doi.org/10.1136/bmjopen-2026-124300"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "heading:Oncology",
      "subfield": "oncology"
    }
  ],
  "title": "Establishing a national platform to facilitate patient recruitment and advanced diagnostics for cancer immunotherapies (the NHS Cancer Vaccine Launch Pad): a multicentre prospective cohort feasibility study protocol",
  "title_text": "Establishing a national platform to facilitate patient recruitment and advanced diagnostics for cancer immunotherapies (the NHS Cancer Vaccine Launch Pad): a multicentre prospective cohort feasibility study protocol",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:22:19Z",
  "url": "https://research.draconitic.com/paper/4ncg7mfxe304m",
  "venue": "BMJ Open",
  "versions": []
}